C/EBPα expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPα confers susceptibility to UVB-induced skin squamous cell carcinomas

Journal of Investigative Dermatology

Volumn 131, Issue 6, 2011, Pages 1339-1346

  Thompson, Elizabeth A ^a   Zhu, Songyun ^a   Hall, Jonathan R ^a   House, John S ^a   Ranjan, Rakesh ^a   Burr, Jeanne A ^a   He, Yu Ying ^b   Owens, David M ^c   Smart, Robert C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA;

ACTINIC KERATOSIS; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; EPIDERMIS; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KERATINOCYTE; KERATOACANTHOMA; MALE; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION;

EID: 79956039252     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.31     Document Type: Article

References (41)

1. American Cancer Society (2008) Cancer Facts & Figures 2008. In: http://www. cancer.org/Research/CancerFactsFigures/cancer-facts-figures-2008
2. Benavides F, Oberyszyn TM, VanBuskirk AM et al. (2009) The hairless mouse in skin research. J Dermatol Sci 53:10-8
3. Bennett KL, Hackanson B, Smith LT et al. (2007) Tumor suppressor activity of CCAAT/e. Cancer Res 67:4657-64
4. Bielas JH, Loeb KR, Rubin BP et al. (2006) Human cancers express a mutator phenotype. Proc Natl Acad Sci USA 103:18238-42 (Pubitemid 44871642)
5. Bielas JH, Loeb LA (2005) Quantification of random genomic mutations. Nat Methods 2:285-90 (Pubitemid 41131010)
6. Brash DE (1997) Sunlight and the onset of skin cancer. Trends Genet 13:410-4
7. Brash DE, Rudolph JA, Simon JA et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-8 (Pubitemid 21915787)
8. Callen JP, Bickers DR, Moy RL (1997) Actinic keratoses. J Am Acad Dermatol 36:650-3 (Pubitemid 27164509)
9. De Gruijl FR, Van Kranen HJ, Mullenders LH (2001) UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 63:19-27 (Pubitemid 33040719)
10. Ding L, Getz G, Wheeler DA et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455:1069-75
11. Foley J, Ton T, Maronpot R et al. (1993) Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ Health Perspect 101(Suppl 5):199-205 (Pubitemid 24096350)
12. Gery S, Tanosaki S, Bose S et al. (2005) Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin Cancer Res 11:3184-90 (Pubitemid 40627863)
13. Giglia-Mari G, Sarasin A (2003) TP53 mutations in human skin cancers. Hum Mutat 21:217-28 (Pubitemid 36292964)
14. Halmos B, Huettner CS, Kocher O et al. (2002) Down-regulation and antiproliferative. Cancer Res 62:528-34
15. Johnson PF (2005) Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci 118:2545-55 (Pubitemid 40932881)
16. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316-23 (Pubitemid 39551659)
17. Kim TW, Porter KL, Foley JF et al. (1997) Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype. Mol Carcinog 20:115-24 (Pubitemid 27461544)
18. Koschmieder S, Halmos B, Levantini E et al. (2009) Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 27:619-28
19. Lee YH, Sauer B, Johnson PF et al. (1997) Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol 17:6014-22 (Pubitemid 27411109)
20. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643-9 (Pubitemid 29003936)
21. Loeb LA, Bielas JH, Beckman RA (2008) Cancers exhibit a mutator phenotype: clinical implications. Cancer Res 68:3551-7; discussion 3557
22. Loomis KD, Zhu S, Yoon K et al. (2007) Genetic ablation of CCAAT/enhancer binding protein \{alpha\. Cancer Res 67:6768-76
23. Maytin EV, Habener JF (1998) Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 110:238-46 (Pubitemid 28144598)
24. Nancarrow DJ, Handoko HY, Smithers BM et al. (2008) Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res 68:4163-72
25. Oh HS, Smart RC (1998) Expression of CCAAT/enhancer binding proteins (C/ EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol 110:939-45 (Pubitemid 28237701)
26. Ortonne JP (2002) From actinic keratosis to squamous cell carcinoma. Br J Dermatol 146(Suppl 61):20-3
27. Pabst T, Mueller BU, Zhang P et al. (2001) Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27:263-70 (Pubitemid 32201846)
28. Ramirez A, Page A, Gandarillas A et al. (2004) A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 39:52-7 (Pubitemid 38738016)
29. Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365:561-75 (Pubitemid 34864439)
30. Ranjan R, Thompson EA, Yoon K et al. (2009) C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint. Oncogene 28:3235-45
31. Rodriguez-Puebla ML, Robles AI, Johnson DG et al. (1998) Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation. Cell Growth Differ 9:31-9 (Pubitemid 28049525)
32. Roesler WJ (2001) The role of C/EBP in nutrient and hormonal regulation of gene expression. Annu Rev Nutr 21:141-65 (Pubitemid 32695268)
33. Schuster MB, Porse BT (2006) C/EBPalpha: a tumour suppressor in multiple tissues? Biochim Biophys Acta 1766:88-103 (Pubitemid 44175631)
34. Shim M, Powers KL, Ewing SJ et al. (2005) Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Cancer Res 65:861-7 (Pubitemid 40216445)
35. Stockfleth E, Kerl H (2006) Guidelines for the management of actinic keratoses. Eur J Dermatol 16:599-606
36. Swart GW, Van Groningen JJ, Van Ruissen F et al. (1997) Transcription factor C/EBPalpha: novel sites of expression and cloning of the human gene. Biol Chem 378:373-9 (Pubitemid 27267578)
37. Takai N, Kawamata N, Walsh CS et al. (2005) Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Mol Cancer Res 3:261-9 (Pubitemid 40656813)
38. The Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-8
39. Thomas-Ahner JM, Wulff BC, Tober KL et al. (2007) Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Res 67:3468-74 (Pubitemid 46724888)
40. Xu L, Hui L, Wang S et al. (2001) Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 61:3176-81 (Pubitemid 32691972)
41. Yoon K, Smart RC (2004) C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol 24:10650-60 (Pubitemid 39603123)